Sean E O'Brien Selected Research

Sean E O'Brien Research Topics

14	Neoplasms (Cancer) 03/2014 - 02/2003
2	Hypoxia (Hypoxemia) 04/2012 - 12/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012
1	Ovarian Neoplasms (Ovarian Cancer) 04/2012
1	Inflammation (Inflammations) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 10/2011
1	Pain (Aches) 03/2011

6	silmitasertibIBA 09/2012 - 12/2010
5	Casein Kinase II (Casein Kinase 2)IBA 09/2012 - 01/2011
4	Carboxylic AcidsIBA 07/2012 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 09/2012 - 04/2012
2	RNA Polymerase I (Polymerase I, RNA)IBA 07/2012 - 02/2011
2	CX 5461IBA 07/2012 - 02/2011
2	proto-oncogene proteins pimIBA 05/2012 - 02/2012
2	Phosphotransferases (Kinase)IBA 01/2012 - 10/2011
1	Tumor Suppressor Protein p53IBA 03/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2012
1	Tyrosine Kinase InhibitorsIBA 09/2012
1	benzo(c)fluoreneIBA 07/2012
1	Ribosomal DNA (rDNA)IBA 07/2012
1	EnzymesIBA 07/2012
1	RNA (Ribonucleic Acid)IBA 07/2012
1	Drug CombinationsIBA 04/2012
1	Gemcitabine FDA Link 04/2012
1	Interleukin-6 (Interleukin 6)IBA 04/2012
1	Cisplatin (Platino)FDA LinkGeneric 04/2012
1	5- (3- ethynylphenylamino)pyrimido(4,5- c)quinoline- 8- carboxylic acidIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 10/2011
1	Formaldehyde (Formol)FDA Link 03/2011
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 02/2011
1	Ribosomal RNAIBA 02/2011
1	Adenosine Triphosphate (ATP)IBA 01/2011
1	BenzothiazolesIBA 02/2003

5	Therapeutics 09/2012 - 03/2011